Infant Bacterial Therapeutics AB (IFTBF) Q4 2025 Earnings

13NovConfirmed
Q3 2024
Q4 2024
Q1 2025
Q4 2025
-0.08
0.25
0.59
0.92

Details

Expected EPS
N/A
Actual EPS
-0.079425
Surprise EPS
-0.08
Surprise Percent
+∞%

Description

Infant Bacterial Therapeutics AB (IFTBF) has reported earnings of -0.079425 per share for Q4 2025.

0 Comments

Share your thoughts